Seaport Global Advisors’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,535
Closed -$232K 89
2023
Q2
$232K Hold
2,535
0.68% 53
2023
Q1
$186K Buy
2,535
+279
+12% +$24.1K 0.59% 70
2022
Q4
$188K Buy
2,256
+346
+18% +$31.2K 0.65% 65
2022
Q3
$185K Sell
1,910
-119
-6% -$14.2K 0.75% 61
2022
Q2
$213K Buy
+2,029
New +$259K 0.79% 53

Other funds holding AMED

Seaport Global Advisors's AMED Position: Q3 2023 in Review

Seaport Global Advisors sold out of Amedisys (AMED) in Q3 2023, closing a stake of 2,535 shares — an estimated $232K sold.

Seaport Global Advisors first reported a position in AMED in Q2 2022 and held it in 5 quarters. The position peaked at $232K in Q2 2023. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2023.

  • Seaport Global Advisors reported no remaining Amedisys position as of Q3 2023 after selling out during the quarter.
  • Seaport Global Advisors sold 2,535 Amedisys shares in Q3 2023, an estimated $232K.
  • Seaport Global Advisors first reported a position in Amedisys in Q2 2022 and held it in 5 quarters.
  • Seaport Global Advisors's Amedisys position peaked at $232K in Q2 2023.
  • 286 funds tracked by Wall St. Rank held Amedisys as of Q3 2023.

Based on Seaport Global Advisors's 13F filing for Q3 2023, filed 15 Nov 2023.